NILO Therapeutics jobs, careers, and hiring context

Explore NILO Therapeutics careers and hiring status. Find jobs at NILO Therapeutics and official application links when roles are open. Funding stage: Series A. Headcount: 11-50. Nilo Therapeutics is a New York-based biotech developing a new class of medicines that harness brain-body neural circuits to restore immune homeostasis. Building on Charles Zuker's Columbia lab discovery of vagal neurons that centrally regulate systemic inflammation, the company targets master-regulator circuits to treat autoimmune and inflammatory disease. Co-founded with The Column Group by Charles Zuker (Columbia), Ruslan Medzhitov (Yale), and Stephen Liberles (Harvard); Kim Seth is CEO.

This page summarizes open roles, company profile signals, and official application paths so candidates can quickly evaluate fit before applying. Use the role list below to identify team focus, review location patterns, and jump to source listings. For broader comparison across the market, continue to the full company directory and jobs explorer.